Connect with us


Samsung Galaxy A70s to launch in India soon



Samsung Galaxy A70s is confirmed to launch in India by the end of this month. The Galaxy A70s will come as a successor to the Galaxy A70 that was launched in India earlier this year for Rs. 28,990. The Galaxy A70s will sport a 64MP rear-facing camera.

It will be the first Samsung device with a 64MP camera sensor. Galaxy A70s will also sport Samsung’s new design language seen in recently launched Galaxy A30s and A50s in India.

The new camera sensor also supports real-time HDR (up to 100 dB), Tetra cell technology, and Super PD phase detection autofocus technology. Additionally, it supports slow-motion video recording in full-HD resolution.

The new smartphone is powered by a 2.0GHz octa-core Snapdragon 675 processor along with Adreno 612 GPU and 6GB/ 8GB RAM. The 128GB internal storage can be further expanded via a microSD card (up to 512GB).

Samsung sold record number (five million) of Galaxy a series phones in just 70 days, achieving $1 billion revenue.


From this day ordinary citizens will start getting corona vaccine made in Russia




Russia’s President Vladimir Putin announced on Tuesday that he had made the corona vaccine.

Also, his daughter has got the vaccine. Since then, there was only one question in the minds of the people, how long will this medicine be available to the common people.

It is being told that the vaccine of covid-19, prepared in Russia, will go into civilian circulation from January 1, 2021, i.e. from this day it will be made accessible to the common people.

Russian Health Minister Mikhail Murashko said that the vaccine for covid-19, developed jointly by the Microbiology Research Center Gamalaya and the Russian Ministry of Defense, will be given to medical personnel and teachers first.

He said, “We will start using it in a phased manner among the common people.

First of all, priority will be given to those who come in contact with the infected person in connection with the work and they are medical personnel and it will also be provided first to those who are responsible for the health of the children i.e. teachers. ”

The Russian Health Minister said that the Gamaleya Research Center Institute and pharmaceutical company Binnopharm JSC would use these two sites to produce the vaccine.

Continue Reading